C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors
Nobuyuki Matsunaga(Takeda (Japan)), Akihiro Tasaka(Takeda (Japan)), Akio Ojida(Kyushu University), Masami Kusaka(Takeda (Japan)), Takahito Hara(Takeda (Japan)), Toshimasa Tanaka(Takeda (Japan)), Masuo Yamaoka, Tomohiro Kaku(Takeda (Japan))
Cited by 56
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound
|Proceedings of the National Academy of Sciences|2009|387
Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent
|Biochemical and Biophysical Research Communications|1991|323
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
|British Journal of Cancer|1994|243